GlassScriptPhysician profile
Michael B Sehy
NPI 1831253582
$6,536.79
in general payments reported to CMS, 2019-2025
21 companies · $628 in 2025
The $628 reported for 2025 was more than what 83% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,508 · 2020: $230 · 2021: $373 · 2022: $2,872 · 2023: $452 · 2024: $474 · 2025: $628.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,475 · Entertainment: $78.98.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,475.30 |
| Entertainment | $78.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $4,284.79 | 2019-2025 | Total30, Precision7, Rocklatan |
| Coopervision INC. | $433.66 | 2019-2025 | Myday Contact Lens |
| Sun Pharmaceutical Industries INC. | $285.00 | 2019-2025 | |
| Johnson & Johnson Vision Care, INC. | $262.61 | 2019-2024 | Acuvue |
| Bausch & Lomb Americas INC. | $219.41 | 2022-2025 | Infuse, Biotrue, Miebo |
| Biotissue Holdings INC. | $139.28 | 2021-2025 | |
| Allergan, INC. | $114.27 | 2019-2020 | |
| Lkc Technologies, INC. | $102.70 | 2025 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $100.60 | 2019-2020 | |
| Abb Con-Cise Optical Group LLC | $91.17 | 2019-2023 | Spectacle Lenses, Contact Lens |
| Optos, INC. | $78.98 | 2024-2025 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Abbvie INC. | $77.48 | 2022 | |
| Novartis Pharmaceuticals Corporation | $73.71 | 2020-2023 | |
| Tarsus Pharmaceuticals, INC. | $64.66 | 2024-2025 | Xdemvy |
| Mallinckrodt Hospital Products INC. | $62.80 | 2025 | Acthar |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shire North American Group INC | $39.51 | 2019 | |
| Lombart Brothers, INC. | $38.78 | 2019 | |
| Dompe US, INC. | $31.31 | 2025 | Oxervate |
| Carl Zeiss Meditec USA, INC. | $14.98 | 2024 | Cirrus Hd-Oct |
| Johnson & Johnson Surgical Vision, INC. | $13.92 | 2021 | |
| Maculogix, INC. | $7.17 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Sehy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.